Las Vegas, NV -- (SBWIRE) -- 10/07/2013 -- PennyStockEarnings team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks. Our Today’s Focus is On: LiveWorld, Inc.(OTCMKTS:LVWD), Data Call Technologies, Inc.(OTCMKTS:DCLT), STELLAR BIOTECH INC(OTCMKTS:SBOTF), Provectus Pharmaceuticals, Inc.(OTCMKTS:PVCT)
LiveWorld, Inc.(OTCMKTS:LVWD) was trading higher by +0.035 points or +12.50% to $0.315.So far, around 598,343.00 shares have changed hands in this session. After opening at $0.30, the stock hit as high as $0.35. However, it traded between $0.17 and $0.49over the last twelve months. LiveWorld, Inc., a social media management and moderation company, provides private-label social network services for global brands enabling them to scale their social media programs through human moderation.
For How Long LVWD will Fight for Profitability? Read This Trend Analysis report
Data Call Technologies, Inc.(OTCMKTS:DCLT) was at $0.0073, showing a -2.67% decrease. Around 20.87 million shares have been traded, versus an-average trading volume of 879,585.00shares. The company is now valued at around $262,628.00. Data Call Technologies, Inc. provides real-time information/content to the digital signage and kiosk community. The company offers Direct Lynk Messenger service, a digital signage product and real-time information service that provides a range of up-to-date information for display.
Has DCLT Found The Bottom And Ready To Gain Momentum? Find Out Here
STELLAR BIOTECH INC(OTCMKTS:SBOTF) moved +6.67 per cent higher at $1.59 and is trading between $1.48 and $1.62 after opening the day at $1.51. Its performance over the last five days remained -9.66%, which stands at +24.22% for a month. Going back further than one month, 1-year performance after recent close was +450.17%. Stellar Biotechnologies, Inc. produces and markets keyhole limpet hemocyanin (KLH), as well as develops technology related to the culture and production of KLH and subunit KLH formulations in the United States and Europe.
Will SBOTF Continue To Move Higher? Find Out Here
Provectus Pharmaceuticals, Inc.(OTCMKTS:PVCT)’s shares rose today, gaining +7.54 per cent to $0.941. The stock is up around +68.04% in 2013 and +53.01% for the last 12 months. Around 945,983.00 shares changed hands so far in this sessioncompared to an-average trading volume of 671,258.00 shares. Provectus Pharmaceuticals, Inc., a development-stage pharmaceutical company, engages in developing pharmaceuticals for oncology and dermatology indications.
Why Should Investors Buy PVCT After The Recent Gain? Just Go Here and Find Out
PennyStockEarnings.com is keen to discover penny stocks with the potential to make short and long-term gains.
PSE Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
PLEASE NOTE WELL: The employees of PennyStockEarnings.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockEarnings.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockEarnings.com is not offering securities for sale. Neither PennyStockEarnings.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockEarnings.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockEarnings.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer Here: http://www.pennystockearnings.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)